The ongoing supply chain disruptions caused by COVID-19 have made one thing clear, says John Bermudez at TraceLink. Pharmaceutical companies need a new and innovative way to work with suppliers and supply chain networks, so they can more quickly adjust to changing conditions, avoid or mitigate disruptions, and ensure that the right medicines are delivered to patients on time, in full (OTIF).